GILEAD SCIENCES, INC.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| 144 | — | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Mar 20, 2026 |
| DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | Mar 20, 2026 |
| ARS | ANNUAL REPORT TO SECURITY HOLDERS | Mar 20, 2026 |
| 4 | FORM 4 | Mar 17, 2026 |
| 4 | FORM 4 | Mar 17, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| 4 | FORM 4 | Mar 12, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| O'Day Daniel Patrick | Chairman & CEO | Sale | 10,000 @ $124.83 | Dec 29, 2025 |
| Dickinson Andrew D | Chief Financial Officer | Sale | 3,000 @ $122.00 | Dec 15, 2025 |
| Mercier Johanna | Chief Commercial Officer | Sale | 3,000 @ $122.00 | Dec 15, 2025 |
| O'Day Daniel Patrick | Chairman & CEO | Sale | 3,212 @ $125.91 | Nov 28, 2025 |
| Dickinson Andrew D | Chief Financial Officer | Sale | 2,500 @ $125.23 | Nov 17, 2025 |
| Mercier Johanna | Chief Commercial Officer | Sale | 25,524 @ $125.83 | Nov 17, 2025 |
| O'Day Daniel Patrick | Chairman & CEO | Sale | 7,978 @ $119.54 | Oct 28, 2025 |
| Dickinson Andrew D | Chief Financial Officer | Sale | 2,500 @ $118.08 | Oct 15, 2025 |
| Mercier Johanna | Chief Commercial Officer | Sale | 3,000 @ $118.08 | Oct 15, 2025 |
| O'Day Daniel Patrick | Chairman & CEO | Sale | 1,961 @ $112.42 | Sep 29, 2025 |